Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-01-04 @ 2:02 AM
Study NCT ID:
NCT06607757
Status:
RECRUITING
Last Update Posted:
2025-04-02
First Post:
2024-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
Sponsor:
GBG Forschungs GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-14
First Submit QC Date:
None
Study First Post Date:
2024-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-28
Last Update Post Date:
2025-04-02
Last Update Post Date Type:
ACTUAL